Photo: Dyi13/Shutterstock
Brazilian health regulator Anvisa denied Indian laboratory Bharat Biotech a certificate of best practices to produce medicines, a requirement to allow the import of Covid-19 vaccine Covaxin.
The decision was published on Brazil’s Federal Register on Tuesday morning. The regulator said the laboratory “did not fulfill manufacturing best practices.”
On Thursday, the federal government asked permission to import 20 million doses of Covaxin, hoping to receive 8 million shots before the end of March.
Latin America’s trend of banning opposition candidates from elections has caught on in an ever-growing…
The São Paulo City Council on Thursday approved legislation authorizing Brazil’s largest city to sign…
The preliminary report on AI regulations presented to Brazil’s Senate last week provides a middle-of-the-road…
In 2000, Formula 1 great Michael Schumacher had just racked up his 41st race win,…
Overall, the worldwide economic outlook has improved according to the Organization for Economic Co-operation and…
“This is f***ing corruption, it has to change,” protested an irate John Textor, owner of…